Dealmakers that are not yet pursuing targets in emerging markets may be putting their legacies at risk, according to participants at an Ernst & Young panel discussion on May 14 in New York.

Cross-border M&A is often considered risky for private equity and strategic buyers alike, but not taking action could be detrimental to a firm’s longevity, explains partner Herb Engert, who heads E&Y ’s strategic growth markets.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.